In the quest for more effective immunotherapies, trispecific antibodies have emerged as a transformative class of biologics. Capable of targeting three distinct molecules or cell types at once, they enhance immune precision and reduce resistance mechanisms in oncology. These molecules represent a significant leap forward from conventional monoclonal or even bispecific antibodies. Among the...